{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:56:37Z","timestamp":1783644997001,"version":"3.55.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T00:00:00Z","timestamp":1541376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1038\/s41590-018-0243-7","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T08:07:55Z","timestamp":1540454875000},"page":"1309-1318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Autocrine\u2013paracrine prostaglandin E2 signaling restricts TLR4 internalization and TRIF signaling"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1368-6366","authenticated-orcid":false,"given":"Darren J.","family":"Perkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreeram","family":"Nallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Koller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8244-2555","authenticated-orcid":false,"given":"Stefanie N.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,5]]},"reference":[{"key":"243_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/41131","volume":"388","author":"R Medzhitov","year":"1997","unstructured":"Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394\u2013397 (1997).","journal-title":"Nature"},{"key":"243_CR2","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","volume":"282","author":"A Poltorak","year":"1998","unstructured":"Poltorak, A. et al. Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085\u20132088 (1998).","journal-title":"Science"},{"key":"243_CR3","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1084\/jem.189.11.1777","volume":"189","author":"R Shimazu","year":"1999","unstructured":"Shimazu, R. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777\u20131782 (1999).","journal-title":"J. Exp. Med."},{"key":"243_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","volume":"33","author":"SW Brubaker","year":"2015","unstructured":"Brubaker, S. W., Bonham, K. S., Zanoni, I. & Kagan, J. C. Innate immune pattern recognition: a cell biological perspective. Annu. Rev. Immunol. 33, 257\u2013290 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"243_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.molimm.2014.06.033","volume":"63","author":"CE Bryant","year":"2015","unstructured":"Bryant, C. E., Symmons, M. & Gay, N. J. Toll-like receptor signalling through macromolecular protein complexes. Mol. Immunol. 63, 162\u2013165 (2015).","journal-title":"Mol. Immunol."},{"key":"243_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ni1569","volume":"9","author":"JC Kagan","year":"2008","unstructured":"Kagan, J. C. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-\u03b2. Nat. Immunol. 9, 361\u2013368 (2008).","journal-title":"Nat. Immunol."},{"key":"243_CR7","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cell.2011.09.051","volume":"147","author":"I Zanoni","year":"2011","unstructured":"Zanoni, I. et al. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147, 868\u2013880 (2011).","journal-title":"Cell"},{"key":"243_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ni1207","volume":"6","author":"Z Jiang","year":"2005","unstructured":"Jiang, Z. et al. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6, 565\u2013570 (2005).","journal-title":"Nat. Immunol."},{"key":"243_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ni921","volume":"4","author":"KA Fitzgerald","year":"2003","unstructured":"Fitzgerald, K. A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491\u2013496 (2003).","journal-title":"Nat. Immunol."},{"key":"243_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1084\/jem.20031023","volume":"198","author":"KA Fitzgerald","year":"2003","unstructured":"Fitzgerald, K. A. et al. LPS-TLR4 signaling to IRF-3\/7 and NF-\u03baB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198, 1043\u20131055 (2003).","journal-title":"J. Exp. Med."},{"key":"243_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.1087262","volume":"301","author":"M Yamamoto","year":"2003","unstructured":"Yamamoto, M. et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301, 640\u2013643 (2003).","journal-title":"Science"},{"key":"243_CR12","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/ni986","volume":"4","author":"M Yamamoto","year":"2003","unstructured":"Yamamoto, M. et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144\u20131150 (2003).","journal-title":"Nat. Immunol."},{"key":"243_CR13","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1084\/jem.20071632","volume":"205","author":"J Maelfait","year":"2008","unstructured":"Maelfait, J. et al. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1\u03b2 maturation by caspase-8. J. Exp. Med. 205, 1967\u20131973 (2008).","journal-title":"J. Exp. Med."},{"key":"243_CR14","doi-asserted-by":"publisher","first-page":"20054","DOI":"10.1073\/pnas.1116302108","volume":"108","author":"S He","year":"2011","unstructured":"He, S., Liang, Y., Shao, F. & Wang, X. Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway. Proc. Natl Acad. Sci. USA 108, 20054\u201320059 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"243_CR15","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.4049\/jimmunol.1402167","volume":"194","author":"K Moriwaki","year":"2015","unstructured":"Moriwaki, K., Bertin, J., Gough, P. J. & Chan, F. K. A. A RIPK3-caspase 8 complex mediates atypical pro-IL-1\u03b2 processing. J. Immunol. 194, 1938\u20131944 (2015).","journal-title":"J. Immunol."},{"key":"243_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev-immunol-030409-101335","volume":"29","author":"JL Casanova","year":"2011","unstructured":"Casanova, J. L., Abel, L. & Quintana-Murci, L. Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu. Rev. Immunol. 29, 447\u2013491 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"243_CR17","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.4049\/jimmunol.1500105","volume":"195","author":"DJ Perkins","year":"2015","unstructured":"Perkins, D. J. et al. Salmonella Typhimurium co-opts the host type I IFN system to restrict macrophage innate immune transcriptional responses selectively. J. Immunol. 195, 2461\u20132471 (2015).","journal-title":"J. Immunol."},{"key":"243_CR18","doi-asserted-by":"publisher","first-page":"e1005572","DOI":"10.1371\/journal.ppat.1005572","volume":"12","author":"E Deriu","year":"2016","unstructured":"Deriu, E. et al. Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through type I interferons. PLoS Pathog. 12, e1005572 (2016).","journal-title":"PLoS Pathog."},{"key":"243_CR19","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.4049\/jimmunol.0902065","volume":"184","author":"T Henry","year":"2010","unstructured":"Henry, T. et al. Type I IFN signaling constrains IL-17A\/F secretion by \u03b3\u03b4 T cells during bacterial infections. J. Immunol. 184, 3755\u20133767 (2010).","journal-title":"J. Immunol."},{"key":"243_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.immuni.2011.12.002","volume":"35","author":"KD Mayer-Barber","year":"2011","unstructured":"Mayer-Barber, K. D. et al. Innate and adaptive interferons suppress IL-1\u03b1 and IL-1\u03b2 production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 35, 1023\u20131034 (2011).","journal-title":"Immunity"},{"key":"243_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1084\/jem.20091746","volume":"207","author":"M Rayamajhi","year":"2010","unstructured":"Rayamajhi, M., Humann, J., Penheiter, K., Andreasen, K. & Lenz, L. L. Induction of IFN-\u03b1\u03b2 enables Listeria monocytogenes to suppress macrophage activation by IFN-\u03b3. J. Exp. Med. 207, 327\u2013337 (2010).","journal-title":"J. Exp. Med."},{"key":"243_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tibs.2004.11.001","volume":"30","author":"K Heyninck","year":"2005","unstructured":"Heyninck, K. & Beyaert, R. A20 inhibits NF-\u03baB activation by dual ubiquitin-editing functions. Trends Biochem. Sci. 30, 1\u20134 (2005).","journal-title":"Trends Biochem. Sci."},{"key":"243_CR23","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nri3313","volume":"12","author":"A Ma","year":"2012","unstructured":"Ma, A. & Malynn, B. A. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat. Rev. Immunol. 12, 774\u2013785 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"243_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1084\/jem.20071108","volume":"205","author":"EE Turer","year":"2008","unstructured":"Turer, E. E. et al. Homeostatic MyD88-dependent signals cause lethal inflammation in the absence of A20. J. Exp. Med. 205, 451\u2013464 (2008).","journal-title":"J. Exp. Med."},{"key":"243_CR25","doi-asserted-by":"publisher","first-page":"22834","DOI":"10.1074\/jbc.M701831200","volume":"282","author":"MW Buczynski","year":"2007","unstructured":"Buczynski, M. W. et al. TLR-4 and sustained calcium agonists synergistically produce eicosanoids independent of protein synthesis in RAW264.7 cells. J. Biol. Chem. 282, 22834\u201322847 (2007).","journal-title":"J. Biol. Chem."},{"key":"243_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1023\/B:IFLA.0000006700.41614.21","volume":"27","author":"CC Hessle","year":"2003","unstructured":"Hessle, C. C., Andersson, B. & Wold, A. E. Gram-negative, but not Gram-positive, bacteria elicit strong PGE2 production in human monocytes. Inflammation 27, 329\u2013332 (2003).","journal-title":"Inflammation"},{"key":"243_CR27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/IAI.26.2.408-414.1979","volume":"26","author":"RN Moore","year":"1979","unstructured":"Moore, R. N., Urbaschek, R., Wahl, L. M. & Mergenhagen, S. E. Prostaglandin regulation of colony-stimulating factor production by lipopolysaccharide-stimulated murine leukocytes. Infect. Immun. 26, 408\u2013414 (1979).","journal-title":"Infect. Immun."},{"key":"243_CR28","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.4049\/jimmunol.172.4.2469","volume":"172","author":"CC Bowman","year":"2004","unstructured":"Bowman, C. C. & Bost, K. L. Cyclooxygenase-2-mediated prostaglandin E2 production in mesenteric lymph nodes and in cultured macrophages and dendritic cells after infection with Salmonella. J. Immunol. 172, 2469\u20132475 (2004).","journal-title":"J. Immunol."},{"key":"243_CR29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99\u2013103 (2014).","journal-title":"Nature"},{"key":"243_CR30","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nri3859","volume":"15","author":"EA Dennis","year":"2015","unstructured":"Dennis, E. A. & Norris, P. C. Eicosanoid storm in infection and inflammation. Nat. Rev. Immunol. 15, 511\u2013523 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"243_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature11351","volume":"490","author":"J Moltke von","year":"2012","unstructured":"von Moltke, J. et al. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature 490, 107\u2013111 (2012).","journal-title":"Nature"},{"key":"243_CR32","doi-asserted-by":"publisher","first-page":"23229","DOI":"10.1074\/jbc.M400443200","volume":"279","author":"L Boulet","year":"2004","unstructured":"Boulet, L. et al. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J. Biol. Chem. 279, 23229\u201323237 (2004).","journal-title":"J. Biol. Chem."},{"key":"243_CR33","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1074\/jbc.R600038200","volume":"282","author":"Y Sugimoto","year":"2007","unstructured":"Sugimoto, Y. & Narumiya, S. Prostaglandin E receptors. J. Biol. Chem. 282, 11613\u201311617 (2007).","journal-title":"J. Biol. Chem."},{"key":"243_CR34","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ni.3538","volume":"17","author":"L Mortimer","year":"2016","unstructured":"Mortimer, L., Moreau, F., MacDonald, J. A. & Chadee, K. NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations. Nat. Immunol. 17, 1176\u20131186 (2016).","journal-title":"Nat. Immunol."},{"key":"243_CR35","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1084\/jem.20061845","volume":"204","author":"ZJ Roberts","year":"2007","unstructured":"Roberts, Z. J. et al. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J. Exp. Med. 204, 1559\u20131569 (2007).","journal-title":"J. Exp. Med."},{"key":"243_CR36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nature01889","volume":"424","author":"K Hoebe","year":"2003","unstructured":"Hoebe, K. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743\u2013748 (2003).","journal-title":"Nature"},{"key":"243_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pharmthera.2013.03.006","volume":"138","author":"V Konya","year":"2013","unstructured":"Konya, V., Marsche, G., Schuligoi, R. & Heinemann, A. E-type prostanoid receptor 4 (EP4) in disease and therapy. Pharmacol. Ther. 138, 485\u2013502 (2013).","journal-title":"Pharmacol. Ther."},{"key":"243_CR38","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/j.1365-2958.2007.05972.x","volume":"66","author":"DJ Perkins","year":"2007","unstructured":"Perkins, D. J., Gray, M. C., Hewlett, E. L. & Vogel, S. N. Bordetella pertussis adenylate cyclase toxin (ACT) induces cyclooxygenase-2 (COX-2) in murine macrophages and is facilitated by ACT interaction with CD11b\/CD18 (Mac-1). Mol. Microbiol. 66, 1003\u20131015 (2007).","journal-title":"Mol. Microbiol."},{"key":"243_CR39","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.4049\/jimmunol.1602072","volume":"198","author":"Z Zas\u0142ona","year":"2017","unstructured":"Zas\u0142ona, Z. et al. The induction of pro-IL-1\u03b2 by lipopolysaccharide requires endogenous prostaglandin E2 production. J. Immunol. 198, 3558\u20133564 (2017).","journal-title":"J. Immunol."},{"key":"243_CR40","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/ni.2397","volume":"13","author":"N Robinson","year":"2012","unstructured":"Robinson, N. et al. Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium. Nat. Immunol. 13, 954\u2013962 (2012).","journal-title":"Nat. Immunol."},{"key":"243_CR41","doi-asserted-by":"publisher","first-page":"e0188600","DOI":"10.1371\/journal.pone.0188600","volume":"12","author":"KL Stefan","year":"2017","unstructured":"Stefan, K. L., Fink, A., Surana, N. K., Kasper, D. L. & Dasgupta, S. Type I interferon signaling restrains IL-10R+ colonic macrophages and dendritic cells and leads to more severe Salmonella colitis. PLoS One 12, e0188600 (2017).","journal-title":"PLoS One"},{"key":"243_CR42","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1145918","volume":"318","author":"N Kayagaki","year":"2007","unstructured":"Kayagaki, N. et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 318, 1628\u20131632 (2007).","journal-title":"Science"},{"key":"243_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.chom.2014.01.010","volume":"15","author":"MS Jabir","year":"2014","unstructured":"Jabir, M. S. et al. Caspase-1 cleavage of the TLR adaptor TRIF inhibits autophagy and \u03b2-interferon production during Pseudomonas aeruginosa infection. Cell Host Microbe 15, 214\u2013227 (2014).","journal-title":"Cell Host Microbe"},{"key":"243_CR44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3565(25)32927-7","volume":"220","author":"W Bothwell","year":"1982","unstructured":"Bothwell, W., Verburg, M., Wynalda, M., Daniels, E. G. & Fitzpatrick, F. A. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics. J. Pharmacol. Exp. Ther. 220, 229\u2013235 (1982).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"243_CR45","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1126\/science.aad9903","volume":"351","author":"R Duffin","year":"2016","unstructured":"Duffin, R. et al. Prostaglandin E2 constrains systemic inflammation through an innate lymphoid cell-IL-22 axis. Science 351, 1333\u20131338 (2016).","journal-title":"Science"},{"key":"243_CR46","doi-asserted-by":"publisher","first-page":"2614","DOI":"10.1074\/jbc.M109440200","volume":"277","author":"H Fujino","year":"2002","unstructured":"Fujino, H., West, K. A. & Regan, J. W. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J. Biol. Chem. 277, 2614\u20132619 (2002).","journal-title":"J. Biol. Chem."},{"key":"243_CR47","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1189\/jlb.0303116","volume":"74","author":"H Jing","year":"2003","unstructured":"Jing, H., Vassiliou, E. & Ganea, D. Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells. J. Leukoc. Biol. 74, 868\u2013879 (2003).","journal-title":"J. Leukoc. Biol."},{"key":"243_CR48","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1016\/S0021-9258(18)60727-6","volume":"263","author":"SL Kunkel","year":"1988","unstructured":"Kunkel, S. L. et al. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263, 5380\u20135384 (1988).","journal-title":"J. Biol. Chem."},{"key":"243_CR49","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.4049\/jimmunol.180.4.2125","volume":"180","author":"XJ Xu","year":"2008","unstructured":"Xu, X. J., Reichner, J. S., Mastrofrancesco, B., Henry, W. L. Jr. & Albina, J. E. Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-\u03b2 production. J. Immunol. 180, 2125\u20132131 (2008).","journal-title":"J. Immunol."},{"key":"243_CR50","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.immuni.2010.09.010","volume":"33","author":"H Husebye","year":"2010","unstructured":"Husebye, H. et al. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 33, 583\u2013596 (2010).","journal-title":"Immunity"},{"key":"243_CR51","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1074\/jbc.M113.499194","volume":"289","author":"T Acker Van","year":"2014","unstructured":"Van Acker, T. et al. The small GTPase Arf6 is essential for the Tram\/Trif pathway in TLR4 signaling. J. Biol. Chem. 289, 1364\u20131376 (2014).","journal-title":"J. Biol. Chem."},{"key":"243_CR52","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.chom.2013.08.001","volume":"14","author":"A Guichard","year":"2013","unstructured":"Guichard, A. et al. Cholera toxin disrupts barrier function by inhibiting exocyst-mediated trafficking of host proteins to intestinal cell junctions. Cell Host Microbe 14, 294\u2013305 (2013).","journal-title":"Cell Host Microbe"},{"key":"243_CR53","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nature09446","volume":"467","author":"A Guichard","year":"2010","unstructured":"Guichard, A. et al. Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11\/Sec15 exocyst. Nature 467, 854\u2013858 (2010).","journal-title":"Nature"},{"key":"243_CR54","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nrmicro3325","volume":"12","author":"A Guichard","year":"2014","unstructured":"Guichard, A., Nizet, V. & Bier, E. RAB11-mediated trafficking in host-pathogen interactions. Nat. Rev. Microbiol. 12, 624\u2013634 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"243_CR55","doi-asserted-by":"publisher","first-page":"e1006603","DOI":"10.1371\/journal.ppat.1006603","volume":"13","author":"A Guichard","year":"2017","unstructured":"Guichard, A. et al. Anthrax edema toxin disrupts distinct steps in Rab11-dependent junctional transport. PLoS Pathog. 13, e1006603 (2017).","journal-title":"PLoS Pathog."},{"key":"243_CR56","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.chom.2016.02.003","volume":"19","author":"V Castiglia","year":"2016","unstructured":"Castiglia, V. et al. Type I interferon signaling prevents IL-1\u03b2-driven lethal systemic hyperinflammation during invasive bacterial infection of soft tissue. Cell Host Microbe 19, 375\u2013387 (2016).","journal-title":"Cell Host Microbe"},{"key":"243_CR57","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1084\/jem.20040976","volume":"200","author":"V Auerbuch","year":"2004","unstructured":"Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O\u2019Riordan, M. & Portnoy, D. A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 200, 527\u2013533 (2004).","journal-title":"J. Exp. Med."},{"key":"243_CR58","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1128\/IAI.00629-08","volume":"76","author":"UM Nagarajan","year":"2008","unstructured":"Nagarajan, U. M. et al. Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect. Immun. 76, 4642\u20134648 (2008).","journal-title":"Infect. Immun."},{"key":"243_CR59","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4049\/jimmunol.170.1.508","volume":"170","author":"MA Dobrovolskaia","year":"2003","unstructured":"Dobrovolskaia, M. A. et al. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR \u201chomotolerance\u201d versus \u201cheterotolerance\u201d on NF-\u03baB signaling pathway components. J. Immunol. 170, 508\u2013519 (2003).","journal-title":"J. Immunol."},{"key":"243_CR60","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1189\/jlb.0410216","volume":"89","author":"KA Shirey","year":"2011","unstructured":"Shirey, K. A. et al. The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-\u03b2-mediated antiviral activity in vitro and in vivo. J. Leukoc. Biol. 89, 351\u2013357 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"243_CR61","doi-asserted-by":"publisher","first-page":"F1035","DOI":"10.1152\/ajprenal.00054.2011","volume":"301","author":"CS Facemire","year":"2011","unstructured":"Facemire, C. S. et al. A major role for the EP4 receptor in regulation of renin. Am. J. Physiol. Renal Physiol. 301, F1035\u2013F1041 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"243_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/36342","volume":"390","author":"M Nguyen","year":"1997","unstructured":"Nguyen, M. et al. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 390, 78\u201381 (1997).","journal-title":"Nature"},{"key":"243_CR63","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/1753425916650027","volume":"22","author":"K Richard","year":"2016","unstructured":"Richard, K., Vogel, S. N. & Perkins, D. J. Type I interferon licenses enhanced innate recognition and transcriptional responses to Franciscella tularensis live vaccine strain. Innate Immun. 22, 363\u2013372 (2016).","journal-title":"Innate Immun."},{"key":"243_CR64","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1021\/bi00860a011","volume":"6","author":"FC McIntire","year":"1967","unstructured":"McIntire, F. C., Sievert, H. W., Barlow, G. H., Finley, R. A. & Lee, A. Y. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6, 2363\u20132372 (1967).","journal-title":"Biochemistry"},{"key":"243_CR65","first-page":"889","volume":"26","author":"SW Barthold","year":"1976","unstructured":"Barthold, S. W., Coleman, G. L., Bhatt, P. N., Osbaldiston, G. W. & Jonas, A. M. The etiology of transmissible murine colonic hyperplasia. Lab. Anim. Sci. 26, 889\u2013894 (1976).","journal-title":"Lab. Anim. Sci."},{"key":"243_CR66","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1086\/315421","volume":"181","author":"A Donohue-Rolfe","year":"2000","unstructured":"Donohue-Rolfe, A., Kondova, I., Oswald, S., Hutto, D. & Tzipori, S. Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2. J. Infect. Dis. 181, 1825\u20131829 (2000).","journal-title":"J. Infect. Dis."},{"key":"243_CR67","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0140-6736(78)90299-4","volume":"1","author":"MM Levine","year":"1978","unstructured":"Levine, M. M. et al. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet 1, 1119\u20131122 (1978).","journal-title":"Lancet"},{"key":"243_CR68","doi-asserted-by":"publisher","first-page":"8391","DOI":"10.1073\/pnas.1424980112","volume":"112","author":"R Rajaiah","year":"2015","unstructured":"Rajaiah, R., Perkins, D. J., Ireland, D. D. & Vogel, S. N. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance. Proc. Natl Acad. Sci. USA 112, 8391\u20138396 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"243_CR69","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2013\u2206\u2206CT) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41590-018-0243-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-018-0243-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-018-0243-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:43:34Z","timestamp":1775252614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-018-0243-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,5]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1038\/s41590-018-0243-7","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,5]]},"assertion":[{"value":"27 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}